Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

MediWound (MDWD) Current Deferred Revenue: 2017-2020

  • MediWound's Current Deferred Revenue rose 85.54% to $462,000 in Q4 2020 from the same period last year, while for Dec 2020 it was $462,000, marking a year-over-year increase of 85.54%. This contributed to the annual value of $462,000 for FY2020, which is 85.54% up from last year.
  • Per MediWound's latest filing, its Current Deferred Revenue stood at $462,000 for Q4 2020, which was up 85.54% from $249,000 recorded in Q4 2019.
  • In the past 5 years, MediWound's Current Deferred Revenue ranged from a high of $462,000 in Q4 2020 and a low of $131,000 during Q4 2017.
  • For the 3-year period, MediWound's Current Deferred Revenue averaged around $303,000, with its median value being $249,000 (2019).
  • Data for MediWound's Current Deferred Revenue shows a peak YoY surged of 85.54% (in 2020) over the last 5 years.
  • Quarterly analysis of 4 years shows MediWound's Current Deferred Revenue stood at $131,000 in 2017, then soared by 51.15% to $198,000 in 2018, then climbed by 25.76% to $249,000 in 2019, then soared by 85.54% to $462,000 in 2020.
  • Its Current Deferred Revenue stands at $462,000 for Q4 2020, versus $249,000 for Q4 2019 and $198,000 for Q4 2018.